{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:07:00Z","timestamp":1793862420399,"version":"4.6.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"am","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1K23HL151672-01"],"award-info":[{"award-number":["1K23HL151672-01"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.cardfail.2023.03.012","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T03:46:16Z","timestamp":1680234376000},"page":"1000-1013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Pharmacist- and Nurse-Led Medical Optimization in Heart Failure: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2009-2059","authenticated-orcid":false,"given":"JIMMY","family":"ZHENG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"THOMAS","family":"MEDNICK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PAUL A.","family":"HEIDENREICH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ALEXANDER T.","family":"SANDHU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2023.03.012_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2021.12.011","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0002","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1016\/j.jacc.2019.02.042","article-title":"Disparities in cardiovascular mortality related to heart failure in the United States","volume":"73","author":"Glynn","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0003","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1161\/CIRCRESAHA.121.318172","article-title":"Epidemiology of heart failure","volume":"128","author":"Roger","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0004","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","article-title":"Medical therapy for heart failure with reduced ejection fraction","volume":"72","author":"Greene","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jacc.2019.11.011","article-title":"Trends in U.S. ambulatory cardiovascular care 2013 to 2017","volume":"75","author":"Maddox","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0006","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/ejhf.2271","article-title":"Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden)","volume":"23","author":"Savarese","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0007","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1001\/jamacardio.2021.4585","article-title":"Evaluation of quality of care for US veterans with recent-onset heart failure with reduced ejection fraction","volume":"7","author":"Sandhu","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0008","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jacc.2020.11.022","article-title":"2021 update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction","volume":"77","author":"Maddox","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0009","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.cardfail.2021.03.012","article-title":"Sacubitril\/valsartan initiation and postdischarge adherence among patients hospitalized for heart failure","volume":"27","author":"Carnicelli","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0010","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.jacc.2019.02.015","article-title":"Titration of medical therapy for heart failure with reduced ejection fraction","volume":"73","author":"Greene","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0011","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/archinte.168.7.687","article-title":"Pharmacist care of patients with heart failure: a systematic review of randomized trials","volume":"168","author":"Koshman","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0012","article-title":"Nurse-led titration of angiotensin converting enzyme inhibitors, beta-adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction. Cochrane Heart Group, ed","volume":"12","author":"Driscoll","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0013","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.cardfail.2019.07.455","article-title":"Effectiveness of the pharmacist-involved multidisciplinary management of heart failure to improve hospitalizations and mortality rates in 4630 patients: a systematic review and meta-analysis of randomized controlled trials","volume":"25","author":"Parajuli","year":"2019","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0014","unstructured":"Higgins J, Thomas J, Chander J, xxx, et al. Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). www.training.cochrane.org\/handbook"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0015","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0016","unstructured":"Zheng J, Mednick T, Sandhu AT. PROSPERO 2022 CRD42022334661. Published 2022. https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=334661"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0017","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0018","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0019","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2288-14-25","article-title":"The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method","volume":"14","author":"IntHout","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0021","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jrsm.1316","article-title":"A comparison of heterogeneity variance estimators in simulated random-effects meta-analyses","volume":"10","author":"Langan","year":"2019","journal-title":"Res Synth Meth"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0022","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0023","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1164","article-title":"Methods to estimate the between-study variance and its uncertainty in meta-analysis","volume":"7","author":"Veroniki","year":"2016","journal-title":"Res Synth Meth"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0024","series-title":"Meta-Analysis with R","author":"Schwarzer","year":"2015"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0025","doi-asserted-by":"crossref","unstructured":"McGuinness LA. robvis: an R package and web application for visualising risk-of-bias assessments. 2019. https:\/\/github.com\/mcguinlu\/robvis","DOI":"10.1002\/jrsm.1411"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0026","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/eurjhf\/hfs159","article-title":"The benefits of using a heart failure management programme in Swedish primary healthcare","volume":"15","author":"Agvall","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0027","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1161\/01.CIR.0000070952.08969.5B","article-title":"Improving guideline adherence: a randomized trial evaluating strategies to increase \u03b2-blocker use in heart failure","volume":"107","author":"Ansari","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0028","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1186\/1756-0500-7-668","article-title":"A nurse-led up-titration clinic improves chronic heart failure optimization of beta-adrenergic receptor blocking therapy - a randomized controlled trial","volume":"7","author":"Driscoll","year":"2014","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0029","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1067\/mhl.2003.5","article-title":"Can treatment with angiotensin-converting enzyme inhibitors in elderly patients with moderate to severe chronic heart failure be improved by a nurse-monitored structured care program? A randomized controlled trial","volume":"32","author":"Ekman","year":"2003","journal-title":"Heart Lung"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0030","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1161\/01.CIR.0000148957.62328.89","article-title":"Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure","volume":"110","author":"Galbreath","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0031","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1001\/archinte.159.16.1939","article-title":"Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) study","volume":"159","author":"Gattis","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0032","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ejhf.252","article-title":"Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling: nurse-coordinated disease management improves therapy and outcomes in HF","volume":"17","author":"G\u00fcder","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0033","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2318-12-70","article-title":"Feasibility of evidence-based diagnosis and management of heart failure in older people in care: a pilot randomised controlled trial","volume":"12","author":"Hancock","year":"2012","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0034","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0735-1097(01)01761-2","article-title":"A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission","volume":"39","author":"Kasper","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0035","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cardfail.2007.12.008","article-title":"Inpatient initiation of \u03b2-blockade plus nurse management in vulnerable heart failure patients: a randomized study","volume":"14","author":"Krantz","year":"2008","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0036","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archinte.163.7.809","article-title":"Case management in a heterogeneous congestive heart failure population: a randomized controlled trial","volume":"163","author":"Laramee","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0037","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/eurheartj\/ehr433","article-title":"Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction","volume":"33","author":"Lowrie","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0038","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.cardfail.2013.06.004","article-title":"Improvement of guideline beta-blocker prescribing in heart failure: a cluster-randomized pragmatic trial of a pharmacy intervention","volume":"19","author":"McCarren","year":"2013","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0039","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.recesp.2020.04.032","article-title":"Noninferiority of heart failure nurse titration versus heart failure cardiologist titration. ETIFIC multicenter randomized trial","volume":"74","author":"Oyanguren","year":"2021","journal-title":"Rev Esp Cardiol Engl Ed"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0040","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/0003-4819-145-4-200608150-00007","article-title":"Effects of nurse management on the quality of heart failure care in minority communities: a randomized trial","volume":"145","author":"Sisk","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0041","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0195-668X(03)00112-X","article-title":"Nurse-led heart failure clinics improve survival and self-care behaviour in patients with heart failure: results from a prospective, randomised trial","volume":"24","author":"Stromberg","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0042","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ejheart.2004.10.008","article-title":"Effects of a nurse-led, clinic and home-based intervention on recurrent hospital use in chronic heart failure","volume":"7","author":"Thompson","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2018.12.004","article-title":"Heart Failure postdischarge clinic: a pharmacist-led approach to reduce readmissions","volume":"44","author":"Al-Bawardy","year":"2019","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0044","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1177\/1060028018760568","article-title":"Outcomes of a pharmacist-managed heart failure medication titration assistance clinic","volume":"52","author":"Bhat","year":"2018","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0045","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.2163","article-title":"Virtual optimization of guideline-directed medical therapy in hospitalized patients with heart failure with reduced ejection fraction: the IMPLEMENT-HF pilot study","volume":"23","author":"Bhatt","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0046","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1177\/1060028019842656","article-title":"Evaluation of pharmacist impact within an interdisciplinary inpatient heart failure consult service","volume":"53","author":"Blizzard","year":"2019","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0047","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1001\/jamacardio.2020.3757","article-title":"Remote optimization of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction","volume":"5","author":"Desai","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0048","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.pcad.2017.07.004","article-title":"Implementation of a patient navigator program to reduce 30-day heart failure readmission rate","volume":"60","author":"Di Palo","year":"2017","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0049","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cardfail.2010.10.010","article-title":"Nurse-led titration of \u03b2-adrenoreceptor blocking agents in chronic heart failure patients in the community","volume":"17","author":"Driscoll","year":"2011","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0050","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3390\/pharmacy8030159","article-title":"Heart failure prescribing quality at discharge from a critical care unit in egypt: the impact of multidisciplinary care","volume":"8","author":"El Hadidi","year":"2020","journal-title":"Pharmacy"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0051","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.clinthera.2017.04.012","article-title":"Impact of a multidisciplinary heart failure postdischarge management clinic on medication adherence","volume":"39","author":"Lu","year":"2017","journal-title":"Clin Ther"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0052","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.2146\/ajhp120267","article-title":"Implementation of a pharmacist-managed heart failure medication titration clinic","volume":"70","author":"Martinez","year":"2013","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0053","first-page":"S10","article-title":"The pharmacist's role in medication optimization for patients with chronic heart failure","volume":"34","author":"Noschese","year":"2017","journal-title":"Fed Pract Health Care Prof VA DoD PHS"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0054","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.japh.2021.11.012","article-title":"Integration of clinical pharmacists into a heart failure clinic within a safety-net hospital","volume":"62","author":"Shah","year":"2022","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0055","first-page":"25","article-title":"Harnessing the potential of primary care pharmacists to improve heart failure management","volume":"48","author":"Slade","year":"2022","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0056","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/0897190017747083","article-title":"Evaluation of a pharmacist-driven aldosterone antagonist stewardship program in patients with heart failure","volume":"32","author":"Sparks","year":"2019","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0057","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00380-017-1099-8","article-title":"Pharmacist-led intervention in the multidisciplinary team approach optimizes heart failure medication","volume":"33","author":"Suzuki","year":"2018","journal-title":"Heart Vessels"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0058","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/jac5.1529","article-title":"Impact of a pharmacist-inclusive post-discharge clinic on outcomes in heart failure patients with reduced ejection fraction: rates of hospital readmission, emergency department visits, or death","volume":"4","author":"Upton","year":"2021","journal-title":"J Am Coll Clin Pharm"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0059","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCULATIONAHA.120.052926","article-title":"How should we sequence the treatments for heart failure and a reduced ejection fraction?: a redefinition of evidence-based medicine","volume":"143","author":"McMurray","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0060","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1161\/CIRCULATIONAHA.120.050582","article-title":"Telehealth for uptitration of guideline-directed medical therapy in heart failure","volume":"142","author":"Thibodeau","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0061","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002493","article-title":"Barriers to adoption of mineralocorticoid receptor antagonists in patients with heart failure: a mixed-methods study","volume":"5","author":"Dev","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0062","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/aje\/kwm189","article-title":"Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? a critical examination of underlying principles","volume":"166","author":"Shrier","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cardfail.2023.03.012_bib0063","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jacbts.2021.10.018","article-title":"Optimizing foundational therapies in patients with HFrEF","volume":"7","author":"Sharma","year":"2022","journal-title":"JACC Basic Transl Sci"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916423001057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916423001057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:50:19Z","timestamp":1761029419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916423001057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":63,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1071916423001057"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2023.03.012","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacist- and Nurse-Led Medical Optimization in Heart Failure: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2023.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}